Marshall Wace’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.52M Buy
485,504
+200,816
+71% +$2.18M 0.01% 1257
2025
Q4
$3.66M Sell
284,688
-53,459
-16% -$660K ﹤0.01% 1294
2025
Q3
$3.78M Sell
338,147
-67,971
-17% -$656K ﹤0.01% 1310
2025
Q2
$4.03M Sell
406,118
-21,956
-5% -$215K ﹤0.01% 1254
2025
Q1
$4.02M Sell
428,074
-48,750
-10% -$512K 0.01% 1170
2024
Q4
$4.37M Buy
476,824
+443,598
+1,335% +$3.26M 0.01% 1117
2024
Q3
$258K Sell
33,226
-34,231
-51% -$247K ﹤0.01% 2207
2024
Q2
$408K Sell
67,457
-218,500
-76% -$1.35M ﹤0.01% 2038
2024
Q1
$1.68M Buy
285,957
+267,357
+1,437% +$1.59M ﹤0.01% 1441
2023
Q4
$146K Sell
18,600
-117,761
-86% -$817K ﹤0.01% 2018
2023
Q3
$997K Buy
+136,361
New +$1.13M ﹤0.01% 1504
2023
Q2
Sell
-28,694
Closed -$297K 2434
2023
Q1
$297K Sell
28,694
-43,271
-60% -$554K ﹤0.01% 2304
2022
Q4
$991K Buy
+71,965
New +$1M ﹤0.01% 2097
2020
Q2
Sell
-33,972
Closed -$354K 1518
2020
Q1
$354K Sell
33,972
-270,114
-89% -$3.39M ﹤0.01% 1054
2019
Q4
$4.87M Buy
304,086
+184,127
+153% +$2.81M 0.03% 543
2019
Q3
$2.21M Buy
119,959
+104,258
+664% +$2.04M 0.02% 737
2019
Q2
$310K Buy
+15,701
New +$320K ﹤0.01% 1177

Other funds holding ANGO

Marshall Wace's ANGO Position: Q1 2026 in Review

Marshall Wace increased its AngioDynamics (ANGO) stake by 71% in Q1 2026, buying an estimated $2.18M and bringing the position to 485,504 shares worth $5.52M. The position accounts for 0.01% of the portfolio, ranked #1257.

Marshall Wace first reported a position in ANGO in Q2 2019 and has held it in 17 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Marshall Wace held 485,504 shares of AngioDynamics worth $5.52M as of Q1 2026.
  • Marshall Wace bought 200,816 AngioDynamics shares in Q1 2026, an estimated $2.18M.
  • AngioDynamics made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1257 holding.
  • Marshall Wace first reported a position in AngioDynamics in Q2 2019 and has held it in 17 quarters since.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.